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 Glaucoma, which is thought to be a chronic
neurodegenerative disease, is the second most common cause
of blindness worldwide [1,2]. Normal tension glaucoma
(NTG), a subset of glaucoma, is an entity with progressive
glaucomatous optic neuropathy and corresponding visual field
defects, but with intraocular pressure (IOP) in the statistically
normal range. Thirty-seven percent of patients with NTG have
a family history of glaucoma, and its higher prevalence in
Korean (2.04%) and Japanese (3.6%) populations than in the
Caucasian population (0.6%) suggests that there might be a
genetic predisposition for NTG [3-6]. Population based asso-
ciation studies using polymorphisms of candidate genes offer
one approach to identify which genes might confer increased
susceptibility to this form of glaucoma.
Endothelin-1 (EDN1), one of the most potent physiologic
vasoconstrictors currently known, has been shown to play an
important role in the pathophsiology of glaucoma through its
various actions, including reduction of blood flow to the optic
nerve head [7]. Endothelin receptor type A (EDNRA) and
endothelin receptor type B (EDNRB) are distinct receptors
that mediate the biological effects of EDN1. Recently, EDNRA
and EDNRB have been located in the region of the optic nerve
head [8]. The stimulation of EDNRA evokes marked and sus-
tained vasoconstriction of vascular smooth muscle cells [9].
In contrast, in endothelial cells, stimulation of EDNRB leads
to release of nitric oxide in some blood vessels, evoking tran-
sient vasodilation [10]. A recent study has suggested that the
GG genotype of EDNRA:c.*70C>G polymorphism is associ-
ated with more severe visual field defects in Japanese NTG
p tients, although genotype distributions of EDN1, EDNRA,
and EDNRB were not associated with open-angle glaucoma
[11].
In this study, we investigated whether polymorphisms of
the EDN1, EDNRA, and EDNRB genes were associated with
NTG in the Korean population. Compared with the Caucasian
population, the Korean population should be a better ethnic
group for genetic studies related to NTG because of its single
ethnic origin and the higher prevalence of NTG.
METHODS
Patient selection:  The study population was composed of 67
patients with NTG and 100 healthy volunteers. All subjects
were of Korean origin and were, to our knowledge, unrelated.
NTG patients were recruited at the Glaucoma Clinic and vol-
unteers at the Health Promotion Clinic of Seoul National Uni-
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versity Hospital. Written informed consent was obtained from
all subjects and the study had the approval of the Institutional
Review Board of the Seoul National University Hospital Clini-
cal Research Institute. The diagnostic criteria for NTG were:
glaucomatous optic neuropathy with corresponding visual field
defects; diurnal IOP persistently below 21 mm Hg without
medication; open anterior chamber angle; and absence of any
known secondary cause for glaucomatous optic neuropathy.
IOP was measured using a Goldmann applanation tonometer
and the baseline IOP was defined as the average of diurnal
measurements taken every 1.5 h from 9 AM to 6 PM. Visual
fields were evaluated using the 30-2 program of the Humphrey
visual field analyzer Model 750 (Zeiss Inc., San Leandro, CA)
or Model 630 (Allergan Inc., San Leandro, CA). Mean devia-
tion (MD) and pattern standard deviation (PSD) of these vi-
sual fields were obtained for the analysis. The first two
perimetric results were excluded in order to avoid learning
effects, and the next two perimetric results were adopted as
baseline values. MD and PSD values were obtained by aver-
aging baseline perimetric values.
Control subjects had a best corrected visual acuity of bet-
ter than 20/25, an IOP below 21 mm Hg, no suspicious find-
ings of glaucoma in the disc or fundus, no family history of
glaucoma, and no evidence of systemic disease such as diabe-
tes and hypertension.
Gene polymorphisms:  Six polymorphisms were identi-
fied through a literature review [12,13]. They were the
EDN1:c.594G>T in exon 5 and EDN1:c.-131dupA in the 5'-
untranslated region (UTR) of the EDN1 gene; the EDNRA:c.-
231G>A in the 5'-UTR, EDNRA:c.*70C>G, and
EDNRA:c.*1222C>T in the 3'-UTR of the EDNRA gene; and
the EDNRB:c.831A>Gin exon 4 of the EDNRB gene. The
genotype of the EDN1:c.594G>T polymorphism was identi-
fied using the restriction fragment length polymorphism
method with mutagenic primers. The genotype of
EDNRA:c.*70C>G was identified using the denaturing high-
performance liquid chromatography (DHPLC) method. The
others were analyzed using the single nucleotide extension
assay. Nomenclature used in this article follows the recom-
mendations from the Human Genome Variation Society [14].
Genomic DNA was extracted from EDTA anticoagulated
peripheral blood leukocytes using a Gentra PureGene DNA
isolation kit (Gentra System, Inc., Minneapolis, MN). Poly-
merase chain reactions (PCR) were carried out in a reaction
volume of 20 µl using 50 ng of genomic DNA, 1X PCR buffer
(10 mM Tris-HCl, pH 8.3), 50 mM KCl, 1.5 mM MgCl
2
, 0.01%
elatin, 200 uM of each dNTP, 20 pmole of each primer (Table
1), and 0.5 units of Taq polymerase (AmpliTaq Gold™; Ap-
plied Biosystems, Foster, CA). Cycling parameters were 10
min at 95 °C, followed by 35 cycles of denaturation at 95 °C
for 30 s, annealing at primer specific temperature for 30 s (Table
1) and extension at 72 °C for 60 s. Final extension was at 72
°C for 7 min.
In the case of EDN1:c.594 G>T, the 184 bp PCR prod-
ucts were digested with HindIII and electrophoresed in a 2%
agarose gel with ethidium bromide. The presence of the G
allele caused the 184 bp PCR product to become two frag-
ments of 160 bp and 24 bp. With EDNRA:c.*70C>G, the geno-
type was identified using the WAVE DHPLC system
(Transgenomic, Inc., Omaha, NE) at 60.2 °C. The resulting
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TABLE 1.
                                                                         Annealing
                                                                        temperature
      SNP          Direction              Primer sequence                  (°C)
----------------   ---------   --------------------------------------   -----------
EDN1:c.-131dupA    Forward     GGCAGAGAGCTGTCCAAGTC                         55
(exon 1)           Reverse     CCCAAAGGAAAACGAAGAAA
                   Snapshot    TCAGCCCAAGTGCCCTTT
EDN1:c.594G>T      Forward     CAGGTTTTGTTTGTGCCAGA                         53
(exon 5)           Reverse     GGTCACATAACGCTCTCTGGAAAG
EDNRA:c.-231G>A    Forward     GGAGAGGCTTCATCCATCC                          53
(exon 1)           Reverse     CCCAGTCCCCGATAAGAAAG
                   Snapshot    gactgactgTTCCCCGGCTTCAGAAAAC
EDNRA:c.*70C>G     Forward     AGTCTGTTCCTTCCCCCAGT                         55
(exon 8)           Reverse     TCGTAGATGTTGTGGGTGGA
EDNRA:c.*1222C>T   Forward     TTTTGAAGTGGCCAGATGAG                         55
(exon 8)           Reverse     AAATGCCCAGCAAAAGTCAC
                   Snapshot    gactgactgacCAGAACTTACGATTCTTCACTT
EDNRB:c.831A>G     Forward     GAAGATAATCATTCCCTGATGAA                      55
(exon 4)           Reverse     CAATCTGCATGCCACTTTTC
                   Snapshot    gactgactgactgactGCAAGCAGAAATAGAAACTGAA
Primers for polymerase chain reaction and single nucleotide extension assay in endothelin-1 (EDN1), endothelin receptor type A (EDNRA),
and endothelin receptor type B (EDNRB) polymorphisms.
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DHPLC trace profiles were examined using Navigator™ soft-
ware. The chromatographs were compared with profiles of
wild-type DNA fragments. Samples with aberrant profiles were
sequenced. In other single nucleotide polymorphisms (SNPs),
the PCR products were pooled and subsequently cleaned up
through incubation with Exo I and SAP (USB Corp., Cleve-
land, OH) at 37 °C for 60 min. Each extension reaction, using
3 µl of PCR product, between 0.05 and 0.5 pmoles of each
primer (Table 1) and 5 µl of SNaPshot Multiplex Ready Re-
action Mix (Applied Biosystems), was carried out by repeat-
ing the following cycle 30 times: 96 °C for 10 s, 40 °C for 5 s,
and 60 °C for 30 s. When completed, 1 U of SAP was added
and the reaction mixture was incubated for 60 min. Then, 0.5
µl of reaction product were mixed with 9.4 µl of formamide
and 0.1 µl of 120 LIZ dye (Applied Biosystems), and ana-
lyzed by ABI Prism 3100 Genetic Analyzer and ABI GeneScan
3.1 analysis software (Applied Biosystems). The design of
primers and probes, as well as the positioning of the SNPs
relative to the translation initiation site of the genes were based
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TABLE 2.
     Characteristics          Patients    Controls   p value
--------------------------   ----------   --------   -------
Age (years)                  47.1±10.4    49.3±9.2     NS
Gender ratio (men:women)     28:39        47:53        NS
IOP (mm Hg)                  16.0±2.4     15.3±2.5     NS
Maximun diurnal IOP          17.3±2.4
Minimum diurnal IOP          14.5±2.8
Family history of glaucoma   14 (20.9%)   0 (0%)
Visual field
  MD (dB)                    -6.54±5.45
  PSD (dB)                    8.34±4.98
Clinical characteristics of normal tension glaucoma patients and con-
trols. In the table, IOP indicates intraocular pressure, MD is mean
deviation of program 30-2 of Humphrey visual field analyzer, and
PSD indicates the pattern standard deviation of program 30-2 of
Humphrey visual field analyzer. Statistical testing was done by inde-
pendent t-test or the χ2 test.
TABLE 3.
    Gene/polymorphism          Genotype     p value    Odds ratio     Allele     p value
--------------------------   ------------   --------   -----------   ---------   -------
Endothelin-1
   EDN1: c.-131dupA          AA   A-   --   AA+A-/--                  A     -
                             --   --   --   --------                 ---   ---
   Patients                  46   21    0    0.3                     113    21    0.96
   Controls                  70   29    1                            169    31
   EDN1:c.594G>T             GG   GT   TT   GG+GT/TT                  G     T
                             --   --   --   --------                 ---   ---
   Patients                  31   29    7    0.76                     91    43    0.27
   Controls                  56   35    9                            147    53
Endothelin receptor type A
   EDNRA: c.-231G>A          GG   GA   AA   GG+GA/AA                  G     A
                             --   --   --   --------                 ---   ---
   Patients                  29   32    6    0.14                     90    44    0.49
   Controls                  44   39   17                            127    73
   EDNRA: c.*70C>G           CC   CG   GG   CC+CG/GG                  C     G
                             --   --   --   --------                 ---   ---
   Patients                  15   38   14    0.32                     68    66    0.50
   Controls                  24   46   30                             94   106
   EDNRA: c.*1222C>T         CC   CT   TT   CC+CT/TT                  C     T
                             --   --   --   --------                 ---   ---
   Patients                  31   26   10    0.028        3.33        88    46    0.22
   Controls                  49   46    5               (95% CI:     144    56
                                                       1.05-10.24)
Endothelin receptor type B
   EDNRB: c.831A>G           AA   AG   GG   AA+AG/GG                  A     G
                             --   --   --   --------                 ---   ---
   Patients                  24   30   13    0.46                     78    56    0.76
   Controls                  28   57   15                            113    87
Distribution of the genotypes and alleles of endothelin-1 (EDN1), endothelin receptor type A (EDNRA), and endothelin receptor type B
(EDNRB) polymorphisms in normal tension glaucoma patients and controls. The p value was obtained by χ2 or Fisher’s exact test.
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on the GenBank sequence of EDN1 (NM_001955), EDNRA
(NM_001957), and EDNRB (NM_000115).
Statistical analysis:  The characteristics of patients were
compared with those of controls using the independent t-test
or χ2 test. Comparisons of the genotype and allele distribu-
tions between patients and controls were performed using the
χ2 test or Fisher’s exact test. Associations of clinical charac-
teristics (baseline IOP, age at diagnosis, MD, and PSD) in NTG
patients with genotypes were assessed using the Mann-
Whitney U test. A value of p<0.05 was considered to be statis-
tically significant. Statistical analysis was performed using
SPSS version 13.0 (SPSS, Chicago, IL).
RESULTS
 There were no differences in age, gender, or intraocular pres-
sure between the patients with NTG and the control group
(Table 2). In all SNPs, there was no evidence to reject the
Hardy-Weinberg equilibrium by the χ2 test. No linkage dis-
equilibrium was found among polymorphisms. Of the six poly-
morphisms, only EDNRA:c.*1222C>T showed a significant
association with NTG (p=0.028, OR=3.33, 95% CI 1.05-10.24;
Table 3). The AA genotype of EDNRA:c.-231G>A was sig-
nificantly associated with the lower baseline IOP than was the
GG+GA genotype group (14.0±2.8 mm Hg versus 16.2± .3
mm Hg, p=0.047; Table 4). The TT genotype of
EDNRA:c.*1222C>T polymorphism showed a younger age
at the time of diagnosis compared to the CC+CT genotype
group, but with no statistical significance (39.1±8.2 years ver-
sus 45.3±10.2 years, p=0.056). All other polymorphisms were
not associated with differences in baseline IOP, age at diagno-
sis, MD, or PSD.
DISCUSSION
 In this study, analysis of the EDN1, EDNRA, and EDNRB
genotypes showed that the polymorphism of
EDNRA:c.*1222C>T was significantly associated with NTG,
and that the AA genotype of EDNRA:c.-231G>A was signifi-
cantly associated with the lower baseline IOP in NTG patients.
EDN1 is a potent vasoconstrictor which is implicated in
the pathogenesis of various vascular diseases [12]. Because
patients with NTG have normal IOP, vascular abnormalities
such as vasospasm or ischemia have been thought to play a
more important role in the pathogenesis of NTG than IOP [15].
Thus, it has been suggested that EDN1 may play a role in
NTG pathogenesis. There are diverse effects of EDN1 upon
the pathophysiology of glaucoma. First, it reduces the blood
flow to the optic nerve head, resulting in ischemia and hy-
poxia [16]. Retinal ganglion cell death in glaucoma is thought
to be initiated following ischemia, which results from pro-
longed vasoconstriction or vasospasm [17]. Second, it alters
the axonal transport of the optic nerve, suggesting that EDN1
may have direct effects upon optic nerve function [18]. Third,
it is thought to promote astrocyte proliferation in the human
optic nerve head [19]. Proliferative astrocytes disrupt axonal
transport, and they inhibit axon regrowth in the glaucomatous
optic nerve head [20]. Fourth, EDN1 induces formation of a
nitrous substance which forms toxic compounds, resulting in
retinal ganglion cell death and optic nerve damage [21,22].
The various actions of EDN1 in glaucoma pathophysiology
are mediated by two receptors, EDNRA and EDNRB, although
the exact function of the receptors has not yet been identified.
It has been thought that the function of EDN1 is maintained
under the balanced influence of two receptors [23]. There-
fore, subjects with qualitatively or quantitatively altered
EDNRA may have dysregulation of vascular tone, or be prone
to mitogenicity or other induction compounds which might
lead to the risk of glaucomatous optic neuropathy in response
to various stimuli.
The functional consequences of EDNRA:c.*1222C>T and
EDNRA:c.-231G>A polymorphisms are unknown, since func-
tional studies are not yet available. However, because
EDNRA:c.*1222C>T polymorphism is in the 3'-UTR and
EDNRA:c.-231G>A polymorphism is in the 5'-UTR, any func-
tional consequences might be related to the regulatory se-
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TABLE 4.
  Polymorphism      Clinical characteristics          Genotype           p value
-----------------   ------------------------   -----------------------   -------
                                                 GG+GA          AA
                                               ----------   ----------
EDNRA: -231G>A      Baseline IOP (mm Hg)       16.2 ±2.3    14.0 ±2.8     0.047
                    Age at diagnosis (years)   43.9 ±10.3   48.7 ±8.0     0.285
                    MD (dB)                    -6.64±5.59   -5.47±3.18    0.839
                    PSD (dB)                    8.31±4.91    9.58±5.67    0.383
                                                 CC+CT          TT
                                               ----------   ----------
EDNRA: c.*1222C>T   Baseline IOP (mm Hg)       16.2 ±2.5    14.8 ±1.5     0.080
                    Age at diagnosis (years)   45.3 ±10.2   39.1 ±8.2     0.056
                    MD (dB)                    -6.68±5.43   -5.74±5.51    0.493
                    PSD (dB)                    8.62±4.85    7.33±5.61    0.482
Associations of clinical characteristics with genotypes of endothelin receptor type A (EDNRA) polymorphisms in normal tension glaucoma
patients. In the table, IOP indicates intraocular pressure, MD shows the mean deviation of program 30-2 of Humphrey visual field analyzer
and PSD indicates the pattern standard deviation of program 30-2 of Humphrey visual field analyzer. The p values were determined using the
Mann-Whitney U test.
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quences of gene transcriptions and be associated with differ-
ences in the level of gene expression. Another possibility is
that such polymorphisms may create novel splice sites and
thus affect the function of a receptor. In addition, such a change
may be associated with other functionally active, but uniden-
tified, gene variants. The functional significance of these poly-
morphisms must be examined and clarified.
A previous study reported that the systemic phenotype of
the EDNRA:c.*1222C>T polymorphism was found to be as-
sociated with pulse pressure, the difference between systolic
and diastolic blood pressure measurements [12]. Although not
affecting the pathophysiology of glaucoma directly, aberra-
tions in pulse pressure might be associated with an alteration
in ocular blood flow. In this study, we did not measure the
plasma EDN1 concentration. However, the EDN1 plasma con-
centration may not reflect vascular production, because EDN1
secretion by endothelial cells is mainly of a paracrine nature
[22]. In addition, endothelin concentration in plasma in pa-
tients with NTG has been controversial [24,25].
In this study, the TT genotype of the EDNRA:c.*1222C>T
polymorphism showed a younger age at the time of diagnosis
compared to the CC+CT genotype group, although there was
no statistical significance. The genetic component is more
important in younger patients than in the older ones. If one
has genetic predisposition to a disease, it is likely that the dis-
ease will develop earlier. Thus, our findings suggest that
EDNRA:c.*1222C>T polymorphism might be one of the ge-
netic risk factors for NTG in the Korean population. One might
argue that there is no way to know when the disease was actu-
ally developed. However, there were no differences in the MD
or PSD of the visual fields between the patients who were
diagnosed at greater than or equal to 40 years of age versus
those less than 40 years (data not shown). Therefore, it seems
less likely that younger patients were detected earlier in the
progress of the disease than were the older ones. We might
also expect that this polymorphism may be associated with
the patients with a family history of the condition. Although a
family history of NTG is as high as 20.9% in the patients in
this study, we can not show the results due to the small num-
ber of patients.
A previous study by Ishihara et al. [11] reported that the
genotype distribution of EDNRA:c.*1222C>T polymorphism
was not significantly different between open-angle glaucoma
patients and normal control subjects in a Japanese population.
However, open-angle glaucoma patients in that study included
those with primary open-angle glaucoma (POAG) as well as
NTG. In addition, that study showed that the frequency of the
CT+TT genotype was higher than in control subjects in
EDNRA:c.*1222C>T at first (p=0.036) as our study presented.
However, control subjects in that study were much older than
glaucoma patients by more than 10 years. Although they per-
formed logistic regression analysis, there might be some se-
lection bias and they were not able to show any significance
after adjusting age. These findings may explain the negative
results of the previous study. Since the genetic component and
the pathophysiology might differ between these two condi-
tions, POAG and NTG, we confined our study to NTG pa-
tients. In addition, racial differences might play a role in caus-
ing the different results, although both Korean and Japanese
races have a high prevalence of NTG.
In this study, we have shown that the genotype of the
EDNRA gene polymorphism was associated with a lower
baseline IOP. Because non-IOP components, such as genetic
factors or vascular abnormality, may play a more important
role in the pathogenesis of NTG patients with lower baseline
IOP, these results support the concept that EDNRA polymor-
phism is related to the genetic risk factor of NTG, and that it is
associated with the pathophysiology of NTG.
A previous study reported that the EDNRA:c.*70C>G
polymorphism was associated with more severe visual field
defects in Japanese NTG patients [11]. We did not find any
association with regard to the visual field defect. In contrast
to the previous study, which used both Goldmann perimetry
and Humphrey automated perimetry, and which used the sub-
jective visual field severity scale, we performed only the
Humphrey automated perimetry and thereby obtained objec-
tive MD and PSD values. We also performed the association
analysis by use of a severity scale as was done in the previous
study [11], but we did not find polymorphism which was as-
sociated with a worse visual field defect (data not shown).
It remains possible that some patients in the control group
could eventually develop NTG, since their average age was
49 years. However, considering the overall prevalence of NTG,
about 2 percent of the Korean population, it is not likely that
age would have affected our results significantly [4].
In conclusion, we have shown that the polymorphism of
EDNRA was associated with NTG and that it was also associ-
ated with a low baseline IOP in our Korean population. Fur-
ther studies will be needed to reveal the functional influence
of polymorphisms of EDNRA on gene expression and/or struc-
ture.
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